Gross Profit - InnoCare Pharma Ltd (SSE:688428) - Alpha Spread

InnoCare Pharma Ltd
SSE:688428

Watchlist Manager
InnoCare Pharma Ltd Logo
InnoCare Pharma Ltd
SSE:688428
Watchlist
Price: 11.33 CNY -2.16% Market Closed
Market Cap: 9.6B CNY
Have any thoughts about
InnoCare Pharma Ltd?
Write Note

InnoCare Pharma Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InnoCare Pharma Ltd
Gross Profit Peer Comparison

Comparables:
6160
1801
9926
603392
300122

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
InnoCare Pharma Ltd
SSE:688428
Gross Profit
ÂĄ482m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Gross Profit
ÂĄ14.7B
CAGR 3-Years
108%
CAGR 5-Years
67%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Gross Profit
ÂĄ5.1B
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Gross Profit
ÂĄ4.4B
CAGR 3-Years
N/A
CAGR 5-Years
335%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Gross Profit
ÂĄ4.5B
CAGR 3-Years
34%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Gross Profit
ÂĄ11.7B
CAGR 3-Years
3%
CAGR 5-Years
26%
CAGR 10-Years
38%

See Also

What is InnoCare Pharma Ltd's Gross Profit?
Gross Profit
482m CNY

Based on the financial report for Dec 31, 2022, InnoCare Pharma Ltd's Gross Profit amounts to 482m CNY.

What is InnoCare Pharma Ltd's Gross Profit growth rate?
Gross Profit CAGR 1Y
-51%

Over the last year, the Gross Profit growth was -51%.

Back to Top